The Covid patient finally got rid of the virus after 411 days of positive testing

The Covid patient finally got rid of the virus after 411 days of positive testing

The Covid patient finally got rid of the virus after 411 days of positive testing

A CORONAVIRUS patient who was positive for 411 days finally got rid of the virus.

Doctors welcomed the cocktail of drugs used to treat the 59-year-old man.

The Covid patient finally got rid of the virus after 411 days of positive testing


In this latest case, the man first tested positive in December 2020Credit: Reuters

Writing in a journal Clinical infectious diseasesdoctors in the UK said the patient was struggling to get rid of an early variant of the bug.

The patient had a weakened immune system after a kidney transplant.

Doctors at Guy’s and St Thomas’ NHS Foundation Trust, Londonand King’s College London said the man was believed to be one of the longest-lived patients with persistent Covid infection.

A previous patient treated by the same team tested positive for Covid for 505 days, but died afterwards.

Urgent warning as 'millions' of Britons are at risk of silent killer due to Covid delays
Covid deaths jump 21% in week as cases 'level off and last wave peaks'

And back in February, another man described being in solitary confinement for 14 months after that test positive for the virus 78 days in a row.

In this latest case, the man tested positive for the first time in December 2020.

While his symptoms resolved, he continued to test positive intermittently until January 2020.

To help treat the patient, medics detected the man’s infection by analyzing the genetics of the virus strain he was carrying.

He was then given a cocktail of neutralizing antibodies (Regeneron) known to be effective against early variants of the coronavirus, which finally allowed his body to rid itself of Covid.

It is very likely that the patient had the original Alpha strain of the virus.

The variant currently on the market in the UK, Omicron, is milder than its predecessors and many people now have the vaccine which also helps protect against severe disease.

But because of the mutating nature of the virus, experts say these antibody treatments are now largely ineffective.

dr. Luke Snell, from Guy’s & St Thomas’, said: “Some new variants of the virus are resistant to all the antibody treatments available in the UK and Europe.

“Some people with weakened immune systems are still at risk of serious illness and persistent infection. We are still working to understand the best way to protect and treat them.”

The ineffectiveness of such drugs has previously been cited as the reason thousands of vulnerable Britons have failed to get hold of them the ‘lifesaving’ drug Evusheld.

Evusheld will provide some protection against viruses to the vulnerable.

It is manufactured by AstraZeneca and was approved by the medicines regulator in March.

Since then, it has also become available in 30 other countries.

Despite widespread use, the British government has said it will not buy more doses until it has more data.

This is due to concerns about how well it will work against the Omicron variant currently circulating in the UK.

The Ministry of Health previously said it was urgently seeking to order a clinical trial of the drug.


Leave a Comment

Your email address will not be published. Required fields are marked *